Please assess the completion status of the following clinical trial:

Trial Title: Study Evaluating The Safety And Effectiveness In Subjects With Tigecycline Treatment

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~Evidence of a personally signed and dated informed consent document indicating that the subject (or a legal representative) has been informed of all pertinent aspects of the study. Subjects must meet all of the following inclusion criteria to be eligible for enrollment into the study :~Adults 18 years of age or older, who have one of the followings:~* Complicated skin and skin structure infections~* Complicated intra-abdominal infections~* Community-acquired bacterial pneumonia~Exclusion Criteria:~Subjects presenting with any of the following will not be included in the study:~* Patients who have known hypersensitivity to tigecycline~* Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency, or glucose-galactose malabsorption

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Patients who have approved indications of Tygacil (Type: None): Approved indications of Tygacil~-complicated intraabdominal infection, complicated skin and skin structure infection, community-acquired bacterial pneumonia

Based on this trial design, predict the completion outcome and termination type (if applicable).